Kevin Robert Lind
CEO & DirectorMr. Kevin Robert Lind is Chief Executive Officer of Apnimed, Inc. from June 2, 2026 and serves as its Director from March 2025. Mr. Lind served as Non-Executive Chairman of the Board of Apnimed, Inc. since March 2025 until June 2, 2026. He serves as an Independent Director at Avalo Therapeutics, Inc. since October 2025. He serves as President and Chief Executive Officer at Longboard Pharmaceuticals, Inc. since March 2020 and also serves as its director since January 2020. He served as Director at Ceek Women's Health, Inc. He joined the Board of Directors in 2021. He serves as Secretary at Longboard Pharmaceuticals, Inc. Mr. Lind served as Chief Financial Officer at Longboard Pharmaceuticals, Inc. from January 2020 to January 2021. He had been the Chief Financial Officer and Executive Vice President at Arena Pharmaceuticals, Inc. from June 15, 2016 to March 15, 2020 and served at Arena Pharmaceuticals, Inc. until October 27, 2020. Mr. Lind served as the Principal Accounting Officer at Arena Pharmaceuticals, Inc. since August 10, 2016. He has experience in healthcare banking and private equity. Mr. Lind is lead underwriter of TOP’s Life Sciences structured investments and drug royalty monetizations effort. Mr. Lind was the Vice President at TPG Biotech. Prior to Arena, Mr. Lind was at TPG, as a Principal at TPG Special Situations Partners and initially at TPG-Axon'sPharma Partners group from January 2009 to June 2016. Mr. Lind was instrumental in the structured and royalty effort at TPG-Axon. Mr. Lind was a Member of the TPG Pharma Partners effort at TPG-Axon from 2006 to 2008. Prior to joining TPG-Axon in 2006, Mr. Lind held experience in Lehman Brothers' Healthcare Investment Banking group, from 1998 to 2002 and 2004 to 2006. where he completed over 20 mergers and acquisitions, partnering agreements and financings for life sciences and medical device companies. Mr. Lind is a Board Observer of Edev S.à.r.l. He was a JDC observer for a structured investment at TPG-Axon. Mr. Lind received an M.B.A. from UCLA Anderson School of Management and a B.S. in Biological Sciences from Stanford University.
Positions
- Company NameApnimed, Inc.Stock CodeAPMDPositionCEO & DirectorColleagues
- PJPaul J. SekhriIndependent Chair of the Board
- LGLawrence G. MillerFounder & Vice Chair of the Board
- DPDennis Patrick MolnarPresident & COO
- LTLuigi Taranto MontemurroCo-Founder & Chief Scientific Officer
- MBMichael B. KellyChief Financial Officer
- PRPaul R. FonteyneIndependent Director
- GLGary L. SenderIndependent Director
